Glycogen metabolism (Homo sapiens)

From WikiPathways

Revision as of 11:22, 9 August 2017 by ReactomeTeam (Talk | contribs)
(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)
Jump to: navigation, search
13, 24, 33, 35, 36, 384, 19, 471614, 31, 353, 2430, 34, 412, 40, 42, 4824, 397, 9, 20168, 2410, 491130, 34, 411666, 1124, 3214, 31, 355, 16, 22, 29, 4310, 216, 116, 116, 1121, 2424, 32165, 22, 29, 4324, 3224, 393, 246, 114, 17, 19, 45, 478, 24112, 18, 37, 40, 42...12, 15, 1612, 15, 16lysosomal lumencytosolpoly((1,4)-alpha-glucosyl)GYG2 phosphorylase kinasecomplex (PHKM)Mg2+ limit dextrin-glycogenin-1 GYG2 RPS27A(1-76) Mg2+ PHKA1 Mg2+ AGLlimitdextrin-glycogenin-2 dimerPGM2 PXLP-p-S15-PYGM Mn2+ UBC(1-76) GYS1 poly((1,4)-alpha-glucosyl)GYG1 PGYM dimer a formGYG1 AMP poly((1,4)-alpha-glucosyl)GYG2 dimerUDP-GlcPGYM b dimer:AMPUDPEPM2A glycogen-GYG1 UBB(1-76) glycogen-GYG2 Mn2+ Mg2+ PPP1R3C GYG2:GYS2-a tetramerGYG1 AMP poly((1,4)-alpha-glucosyl)GYG1 NHLRC1glycogen-GYG2 UGP2 Mg2+ UBC(457-532) limit dextrin-glycogenin-1 PHKG2 GYS2 H2Opoly((1,4)-alpha-glucosyl)GYG2 UBA52(1-76) p-S-GYS1 UDP-GlcUMPPPP1R3Cpoly((1,4)-alpha-glucosyl)GYG dimerMn2+ GAA (70, 76 kDa)PGM2 K48polyUb-EPM2APXLP-PYGB polyGlc-GYG2:GYS2-atetramerGYG2:GYS2-b tetramerGYS1 Mg2+ p-S-GYS1 PPP1R3C:phosphoglycogen-GYG2:GYS2-a tetramerGYG2 PXLP-p-S15-PYGM AMP PHKG1 PPiactive PYGM and PYGBdimersCALM1 PXLP-p-S15-PYGL GYS1 UTPphosphorylase kinasecomplex (PHKL)AMPpoly((1,4)-alpha-glucosyl)GYG dimerPXLP-p-S14-PYGB Mg2+ PGM2L1 poly((1,4)-alpha-glucosyl)GYG1 PGM1 Mg2+ poly((1,4)-alpha-glucosyl)GYG dimerPPP1R3C limitdextrin-glycogenin-1 dimerUBC(305-380) PGYB dimer a formG6PPHKB PPP1R3C UDPMg2+ PPP1R3C:glycogen-GYG1:GYS1-a tetramerEPM2A Ca2+GYS2 GYS1 GYG2 dimerPPP1R3C H2OMn2+ oligo((1,4)-alpha-glycosyl) GYG2 UbEPM2A UBC(381-456) Mg2+ UDP-Glc((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl)GYG1 poly((1,4)-alpha-glucosyl)GYG1 ((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl)GYG2 UBB(77-152) UBC(77-152) oligoGlc-GYG2:GYS2-atetramerPPP1R3C AMPPXLP-PYGB poly((1,4)-alpha-glucosyl)GYG2 Mg2+ PXLP-PYGM Mg2+ ((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl)GYG2 poly((1,4)-alpha-glucosyl)GYG dimerK48polyUb-PPP1R3CPGM1 PiGYS1 ATPglycogen-GYG1 PGYL dimer b formMg2+ p-S-GYS2 Mg2+ limit dextrin-glycogenin-2 PPP1R3C:phosphoglycogen-GYG1:GYS1-a tetramerpoly((1,4)-alpha-glucosyl)GYG1 dimerMg2+ PPP1R3C Mg2+ EPM2A:PPP1R3C:phosphoglycogen-GYG1:GYS1-a tetramerG1PEPM2A PPP1R3C oligo((1,4)-alpha-glycosyl) GYG2 GYG2 G6PEPM2A Mn2+ Mg2+ UBC(153-228) Mn2+ polysaccharide-P-GYG2 EPM2A:PPP1R3C:glycogen-GYG2:GYS2-a tetramerUBB(153-228) oligoGlc-GYG2:GYS2-btetramerMg2+ poly((1,4)-alpha-glucosyl)GYG1 glycogen-GYG2 PPP1R3C:glycogen-GYG2:GYS2-a tetramerGlcPGYB b dimer:AMPPGYM dimer, b formPiPGM2L1 G6Ppoly((1,4)-alpha-glucosyl)GYG2 Mn2+ poly((1,4)-alpha-glucosyl)GYG1 Mg2+ UBC(609-684) GBE1glycogen-GYG1 CALM1 glycogen-GYG1 ATPglycogen-GYG2 Mn2+ limit dextrin-glycogenin-2 GlcGYS2 Mg2+ PPP1R3C p-S-GYS1 glycogen-glycogenin-2 dimerGYG1 dimerlimitdextrin-glycogenindimerMg2+ PXLP-p-S14-PYGB Mn2+ GYS2 poly((1,4)-alpha-glucosyl)GYG2 ((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl)GYG dimerpoly((1,4)-alpha-glucosyl)GYG2 PXLP-PYGM polysaccharide-P-GYG1 ADP((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl)GYG dimerGAA (204-?) Glcoligo((1,4)-alpha-glucosyl) GYG1 GYS2 p-S-GYS2 glycogen-GYG1 Mn2+ Mn2+ PGYB dimer b formEPM2A:PPP1R3C:glycogen-GYG1:GYS1-a tetramerMg2+ Mn2+ GYS1 oligoGlc-GYG1:GYS1-btetramerGYS1 GYS2 glycogen-GYG2:GYS2-atetramerEPM2A:PPP1R3C:phosphoglycogen-GYG2:GYS2-a tetrameroligo((1,4)-alpha-glucosyl) GYG1 Ca2+Mn2+ PiG1PPHKA2 PGM:Mg2+polyGlc-GYG1:GYS1-atetramerpoly((1,4)-alpha-glucosyl)GYG1 GYG1:GYS1-b tetramerG1PUBC(229-304) polysaccharide-P-GYG1 glycogen-GYG1:GYS1-atetramerpolysaccharide-P-GYG2 GYS2 PXLP-PYGM ATPMg2+ p-S-GYS1 GYG1 H2O8xUGP2PHKB PXLP-PYGB glycogen-glycogenin-1 dimerEPM2A dimerGYS2 oligoGlc-GYG1:GYS1-atetramerPGM:Mg2+PXLP-PYGL UBC(533-608) Mg2+ polyGlc-GYG1:GYS1-btetramerMn2+ G6PMn2+ ADP((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl)GYG1 PiGYS1 glycogen-GYG1:GYS1-btetramerPGYL dimer a formGAA (123-?) GYG1:GYS1-a tetramer111, 231, 23261, 231, 2316, 431, 231, 3, 23, 461, 3, 23, 4614, 3130, 4128112828161, 3, 23, 461, 251, 2330, 4116, 27, 30, 4116, 27, 30, 4112828162812628122814, 311, 251, 231, 231, 25261, 231, 2310, 49261, 231, 23


Description

Glycogen, a highly branched glucose polymer, is formed and broken down in most human tissues, but is most abundant in liver and muscle, where it serves as a major stored fuel. Glycogen metabolism has been studied in most detail in liver and skeletal muscle. Glycogen metabolism in other tissues has not been studied as extensively, and is thought to resemble the muscle process.
Glycogen synthesis involves five reactions. The first two, conversion of glucose 6-phosphate to glucose 1-phosphate and synthesis of UDP-glucose from glucose 1-phosphate and UTP, are shared with several other pathways. The next three reactions, the auto-catalyzed synthesis of a glucose oligomer on glycogenin, the linear extension of the glucose oligomer catalyzed by glycogen synthase, and the formation of branches catalyzed by glycogen branching enzyme, are unique to glycogen synthesis. Repetition of the last two reactions generates large, extensively branched glycogen polymers. The catalysis of glycogenin glucosylation and oligoglucose chain extension by distinct isozymes in liver and nonhepatic tissues allows them to be regulated independently (Agius 2008; Bollen et al. 1998; Roach et al. 2012).
Cytosolic glycogen breakdown occurs via the same chemical steps in all tissues but is separately regulated via tissue specific isozymes and signaling pathways that enable distinct physiological fates for glycogen in liver and other tissues. Glycogen phosphorylase, which can be activated by phosphorylase kinase, catalyzes the removal of glucose residues as glucose 1-phosphate from the ends of glycogen branches. The final four residues of each branch are removed in two steps catalyzed by debranching enzyme, and further glycogen phosphorylase activity completes the process of glycogen breakdown. The first glucose residue in each branch is released as free glucose; all other residues are released as glucose 1-phosphate. The latter molecule can be converted to glucose 6-phosphate in a step shared with other pathways (Villar-Palasi & Larner 1970; Hers 1976).
Glycogen can also be taken up into lysosomes, where it is normally broken done by the action of a single enzyme, lysosomal alpha-glucosidase (GAA) (Brown et al. 1970). View original pathway at:Reactome.

Comments

Reactome-Converter 
Pathway is converted from Reactome ID: 8982491
Reactome-version 
Reactome version: 61

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. March RE, Putt W, Hollyoake M, Ives JH, Lovegrove JU, Hopkinson DA, Edwards YH, Whitehouse DB.; ''The classical human phosphoglucomutase (PGM1) isozyme polymorphism is generated by intragenic recombination.''; PubMed Europe PMC Scholia
  2. Nitschke F, Wang P, Schmieder P, Girard JM, Awrey DE, Wang T, Israelian J, Zhao X, Turnbull J, Heydenreich M, Kleinpeter E, Steup M, Minassian BA.; ''Hyperphosphorylation of glucosyl C6 carbons and altered structure of glycogen in the neurodegenerative epilepsy Lafora disease.''; PubMed Europe PMC Scholia
  3. Villar-Palasi C, Larner J.; ''Glycogen metabolism and glycolytic enzymes.''; PubMed Europe PMC Scholia
  4. Gibbons BJ, Roach PJ, Hurley TD.; ''Crystal structure of the autocatalytic initiator of glycogen biosynthesis, glycogenin.''; PubMed Europe PMC Scholia
  5. Roach PJ, Depaoli-Roach AA, Hurley TD, Tagliabracci VS.; ''Glycogen and its metabolism: some new developments and old themes.''; PubMed Europe PMC Scholia
  6. Worby CA, Gentry MS, Dixon JE.; ''Laforin, a dual specificity phosphatase that dephosphorylates complex carbohydrates.''; PubMed Europe PMC Scholia
  7. Veiga-da-Cunha M, Vleugels W, Maliekal P, Matthijs G, Van Schaftingen E.; ''Mammalian phosphomannomutase PMM1 is the brain IMP-sensitive glucose-1,6-bisphosphatase.''; PubMed Europe PMC Scholia
  8. Brown BI, Brown DH, Jeffrey PL.; ''Simultaneous absence of alpha-1,4-glucosidase and alpha-1,6-glucosidase activities (pH 4) in tissues of children with type II glycogen storage disease.''; PubMed Europe PMC Scholia
  9. van den Berg IE, van Beurden EA, Malingré HE, van Amstel HK, Poll-The BT, Smeitink JA, Lamers WH, Berger R.; ''X-linked liver phosphorylase kinase deficiency is associated with mutations in the human liver phosphorylase kinase alpha subunit.''; PubMed Europe PMC Scholia
  10. Newgard CB, Hwang PK, Fletterick RJ.; ''The family of glycogen phosphorylases: structure and function.''; PubMed Europe PMC Scholia
  11. Shen J, Bao Y, Liu HM, Lee P, Leonard JV, Chen YT.; ''Mutations in exon 3 of the glycogen debranching enzyme gene are associated with glycogen storage disease type III that is differentially expressed in liver and muscle.''; PubMed Europe PMC Scholia
  12. Chen YT, He JK, Ding JH, Brown BI.; ''Glycogen debranching enzyme: purification, antibody characterization, and immunoblot analyses of type III glycogen storage disease.''; PubMed Europe PMC Scholia
  13. Hers HG.; ''The control of glycogen metabolism in the liver.''; PubMed Europe PMC Scholia
  14. Maichele AJ, Burwinkel B, Maire I, Søvik O, Kilimann MW.; ''Mutations in the testis/liver isoform of the phosphorylase kinase gamma subunit (PHKG2) cause autosomal liver glycogenosis in the gsd rat and in humans.''; PubMed Europe PMC Scholia
  15. Agius L.; ''Glucokinase and molecular aspects of liver glycogen metabolism.''; PubMed Europe PMC Scholia
  16. Moslemi AR, Lindberg C, Nilsson J, Tajsharghi H, Andersson B, Oldfors A.; ''Glycogenin-1 deficiency and inactivated priming of glycogen synthesis.''; PubMed Europe PMC Scholia
  17. Levine S, Illett TA, Hagman E, Hansen RG.; ''Uridine diphosphate glucose pyrophosphorylase. II.''; PubMed Europe PMC Scholia
  18. Irimia JM, Tagliabracci VS, Meyer CM, Segvich DM, DePaoli-Roach AA, Roach PJ.; ''Muscle glycogen remodeling and glycogen phosphate metabolism following exhaustive exercise of wild type and laforin knockout mice.''; PubMed Europe PMC Scholia
  19. DePaoli-Roach AA, Tagliabracci VS, Segvich DM, Meyer CM, Irimia JM, Roach PJ.; ''Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin.''; PubMed Europe PMC Scholia
  20. Skurat AV, Dietrich AD, Roach PJ.; ''Interaction between glycogenin and glycogen synthase.''; PubMed Europe PMC Scholia
  21. Mu J, Roach PJ.; ''Characterization of human glycogenin-2, a self-glucosylating initiator of liver glycogen metabolism.''; PubMed Europe PMC Scholia
  22. Drago GA, Hopkinson DA, Westwood SA, Whitehouse DB.; ''Antigenic analysis of the major human phosphoglucomutase isozymes: PGM1, PGM2, PGM3 and PGM4.''; PubMed Europe PMC Scholia
  23. Hoefsloot LH, Hoogeveen-Westerveld M, Kroos MA, van Beeumen J, Reuser AJ, Oostra BA.; ''Primary structure and processing of lysosomal alpha-glucosidase; homology with the intestinal sucrase-isomaltase complex.''; PubMed Europe PMC Scholia
  24. Tagliabracci VS, Heiss C, Heiss C, Karthik C, Contreras CJ, Glushka J, Ishihara M, Azadi P, Hurley TD, DePaoli-Roach AA, Roach PJ.; ''Phosphate incorporation during glycogen synthesis and Lafora disease.''; PubMed Europe PMC Scholia
  25. Bollen M, Keppens S, Stalmans W.; ''Specific features of glycogen metabolism in the liver.''; PubMed Europe PMC Scholia
  26. Cameron JM, Levandovskiy V, MacKay N, Utgikar R, Ackerley C, Chiasson D, Halliday W, Raiman J, Robinson BH.; ''Identification of a novel mutation in GYS1 (muscle-specific glycogen synthase) resulting in sudden cardiac death, that is diagnosable from skin fibroblasts.''; PubMed Europe PMC Scholia
  27. Burwinkel B, Rootwelt T, Kvittingen EA, Chakraborty PK, Kilimann MW.; ''Severe phenotype of phosphorylase kinase-deficient liver glycogenosis with mutations in the PHKG2 gene.''; PubMed Europe PMC Scholia
  28. Huang CY, Graves DJ.; ''Correlation between subunit interactions and enzymatic activity of phosphorylase a. Method for determining equilibrium constants from initial rate measurements.''; PubMed Europe PMC Scholia
  29. Brushia RJ, Walsh DA.; ''Phosphorylase kinase: the complexity of its regulation is reflected in the complexity of its structure.''; PubMed Europe PMC Scholia
  30. KELLER PJ, CORI GT.; ''Enzymic conversion of phosphorylase a to phosphorylase b.''; PubMed Europe PMC Scholia
  31. Worby CA, Gentry MS, Dixon JE.; ''Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG).''; PubMed Europe PMC Scholia
  32. Raththagala M, Brewer MK, Parker MW, Sherwood AR, Wong BK, Hsu S, Bridges TM, Paasch BC, Hellman LM, Husodo S, Meekins DA, Taylor AO, Turner BD, Auger KD, Dukhande VV, Chakravarthy S, Sanz P, Woods VL, Li S, Vander Kooi CW, Gentry MS.; ''Structural mechanism of laforin function in glycogen dephosphorylation and lafora disease.''; PubMed Europe PMC Scholia
  33. DePaoli-Roach AA, Contreras CJ, Segvich DM, Heiss C, Ishihara M, Azadi P, Roach PJ.; ''Glycogen phosphomonoester distribution in mouse models of the progressive myoclonic epilepsy, Lafora disease.''; PubMed Europe PMC Scholia
  34. Duggleby RG, Chao YC, Huang JG, Peng HL, Chang HY.; ''Sequence differences between human muscle and liver cDNAs for UDPglucose pyrophosphorylase and kinetic properties of the recombinant enzymes expressed in Escherichia coli.''; PubMed Europe PMC Scholia
  35. Orho M, Bosshard NU, Buist NR, Gitzelmann R, Aynsley-Green A, Blümel P, Gannon MC, Nuttall FQ, Groop LC.; ''Mutations in the liver glycogen synthase gene in children with hypoglycemia due to glycogen storage disease type 0.''; PubMed Europe PMC Scholia
  36. Cao Y, Mahrenholz AM, DePaoli-Roach AA, Roach PJ.; ''Characterization of rabbit skeletal muscle glycogenin. Tyrosine 194 is essential for function.''; PubMed Europe PMC Scholia
  37. Westphal SA, Nuttall FQ.; ''Comparative characterization of human and rat liver glycogen synthase.''; PubMed Europe PMC Scholia
  38. Knop JK, Hansen RG.; ''Uridine diphosphate glucose pyrophosphorylase. IV. Crystallization and properties of the enzyme from human liver.''; PubMed Europe PMC Scholia
  39. Wisselaar HA, Kroos MA, Hermans MM, van Beeumen J, Reuser AJ.; ''Structural and functional changes of lysosomal acid alpha-glucosidase during intracellular transport and maturation.''; PubMed Europe PMC Scholia
  40. Maliekal P, Sokolova T, Vertommen D, Veiga-da-Cunha M, Van Schaftingen E.; ''Molecular identification of mammalian phosphopentomutase and glucose-1,6-bisphosphate synthase, two members of the alpha-D-phosphohexomutase family.''; PubMed Europe PMC Scholia
  41. Putt W, Ives JH, Hollyoake M, Hopkinson DA, Whitehouse DB, Edwards YH.; ''Phosphoglucomutase 1: a gene with two promoters and a duplicated first exon.''; PubMed Europe PMC Scholia
  42. Bao Y, Kishnani P, Wu JY, Chen YT.; ''Hepatic and neuromuscular forms of glycogen storage disease type IV caused by mutations in the same glycogen-branching enzyme gene.''; PubMed Europe PMC Scholia
  43. Rath VL, Ammirati M, LeMotte PK, Fennell KF, Mansour MN, Danley DE, Hynes TR, Schulte GK, Wasilko DJ, Pandit J.; ''Activation of human liver glycogen phosphorylase by alteration of the secondary structure and packing of the catalytic core.''; PubMed Europe PMC Scholia
  44. Sankhala RS, Koksal AC, Ho L, Nitschke F, Minassian BA, Cingolani G.; ''Dimeric quaternary structure of human laforin.''; PubMed Europe PMC Scholia
  45. Gentry MS, Worby CA, Dixon JE.; ''Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin.''; PubMed Europe PMC Scholia
  46. Tagliabracci VS, Turnbull J, Wang W, Girard JM, Zhao X, Skurat AV, Delgado-Escueta AV, Minassian BA, Depaoli-Roach AA, Roach PJ.; ''Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo.''; PubMed Europe PMC Scholia
  47. Mu J, Skurat AV, Roach PJ.; ''Glycogenin-2, a novel self-glucosylating protein involved in liver glycogen biosynthesis.''; PubMed Europe PMC Scholia
  48. Burwinkel B, Hu B, Schroers A, Clemens PR, Moses SW, Shin YS, Pongratz D, Vorgerd M, Kilimann MW.; ''Muscle glycogenosis with low phosphorylase kinase activity: mutations in PHKA1, PHKG1 or six other candidate genes explain only a minority of cases.''; PubMed Europe PMC Scholia
  49. Barbetti F, Rocchi M, Bossolasco M, Cordera R, Sbraccia P, Finelli P, Consalez GG.; ''The human skeletal muscle glycogenin gene: cDNA, tissue expression and chromosomal localization.''; PubMed Europe PMC Scholia
  50. Müller S, Dennemärker J, Reinheckel T.; ''Specific functions of lysosomal proteases in endocytic and autophagic pathways.''; PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
114675view16:14, 25 January 2021ReactomeTeamReactome version 75
113122view11:18, 2 November 2020ReactomeTeamReactome version 74
112356view15:28, 9 October 2020ReactomeTeamReactome version 73
101257view11:15, 1 November 2018ReactomeTeamreactome version 66
100795view20:42, 31 October 2018ReactomeTeamreactome version 65
100337view19:20, 31 October 2018ReactomeTeamreactome version 64
99882view16:02, 31 October 2018ReactomeTeamreactome version 63
99439view14:37, 31 October 2018ReactomeTeamreactome version 62 (2nd attempt)
93411view11:22, 9 August 2017ReactomeTeamNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl)GYG dimerComplexR-HSA-453350 (Reactome)
((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl)GYG dimerComplexR-HSA-5357551 (Reactome)
((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl)GYG1 ProteinP46976 (Uniprot-TrEMBL)
((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl)GYG2 ProteinO15488 (Uniprot-TrEMBL)
8xUGP2ComplexR-HSA-70281 (Reactome)
ADPMetaboliteCHEBI:16761 (ChEBI)
AGLProteinP35573 (Uniprot-TrEMBL)
AMP MetaboliteCHEBI:16027 (ChEBI)
AMPMetaboliteCHEBI:16027 (ChEBI)
ATPMetaboliteCHEBI:15422 (ChEBI)
CALM1 ProteinP62158 (Uniprot-TrEMBL)
Ca2+MetaboliteCHEBI:29108 (ChEBI)
EPM2A ProteinO95278 (Uniprot-TrEMBL)
EPM2A dimerComplexR-HSA-6805697 (Reactome)
EPM2A:PPP1R3C:glycogen-GYG1:GYS1-a tetramerComplexR-HSA-3781000 (Reactome)
EPM2A:PPP1R3C:glycogen-GYG2:GYS2-a tetramerComplexR-HSA-3780991 (Reactome)
EPM2A:PPP1R3C:phosphoglycogen-GYG1:GYS1-a tetramerComplexR-HSA-3780999 (Reactome)
EPM2A:PPP1R3C:phosphoglycogen-GYG2:GYS2-a tetramerComplexR-HSA-3781017 (Reactome)
G1PMetaboliteCHEBI:16077 (ChEBI)
G6PMetaboliteCHEBI:17665 (ChEBI)
GAA (123-?) ProteinP10253 (Uniprot-TrEMBL)
GAA (204-?) ProteinP10253 (Uniprot-TrEMBL)
GAA (70, 76 kDa)ComplexR-HSA-5357562 (Reactome)
GBE1ProteinQ04446 (Uniprot-TrEMBL)
GYG1 ProteinP46976 (Uniprot-TrEMBL)
GYG1 dimerComplexR-HSA-70203 (Reactome)
GYG1:GYS1-a tetramerComplexR-HSA-3322050 (Reactome)
GYG1:GYS1-b tetramerComplexR-HSA-3322062 (Reactome)
GYG2 ProteinO15488 (Uniprot-TrEMBL)
GYG2 dimerComplexR-HSA-70214 (Reactome)
GYG2:GYS2-a tetramerComplexR-HSA-3322031 (Reactome)
GYG2:GYS2-b tetramerComplexR-HSA-3322065 (Reactome)
GYS1 ProteinP13807 (Uniprot-TrEMBL)
GYS2 ProteinP54840 (Uniprot-TrEMBL)
GlcMetaboliteCHEBI:17925 (ChEBI)
H2OMetaboliteCHEBI:15377 (ChEBI)
K48polyUb-EPM2AProteinO95278 (Uniprot-TrEMBL)
K48polyUb-PPP1R3CProteinQ9UQK1 (Uniprot-TrEMBL)
Mg2+ MetaboliteCHEBI:18420 (ChEBI)
Mn2+ MetaboliteCHEBI:29035 (ChEBI)
NHLRC1ProteinQ6VVB1 (Uniprot-TrEMBL)
PGM1 ProteinP36871 (Uniprot-TrEMBL)
PGM2 ProteinQ96G03 (Uniprot-TrEMBL)
PGM2L1 ProteinQ6PCE3 (Uniprot-TrEMBL)
PGM:Mg2+ComplexR-HSA-453132 (Reactome)
PGYB b dimer:AMPComplexR-HSA-453332 (Reactome)
PGYB dimer a formComplexR-HSA-71869 (Reactome)
PGYB dimer b formComplexR-HSA-71863 (Reactome)
PGYL dimer a formComplexR-HSA-71586 (Reactome)
PGYL dimer b formComplexR-HSA-71581 (Reactome)
PGYM b dimer:AMPComplexR-HSA-453344 (Reactome)
PGYM dimer a formComplexR-HSA-71513 (Reactome)
PGYM dimer, b formComplexR-HSA-71538 (Reactome)
PHKA1 ProteinP46020 (Uniprot-TrEMBL)
PHKA2 ProteinP46019 (Uniprot-TrEMBL)
PHKB ProteinQ93100 (Uniprot-TrEMBL)
PHKG1 ProteinQ16816 (Uniprot-TrEMBL)
PHKG2 ProteinP15735 (Uniprot-TrEMBL)
PPP1R3C ProteinQ9UQK1 (Uniprot-TrEMBL)
PPP1R3C:glycogen-GYG1:GYS1-a tetramerComplexR-HSA-3777096 (Reactome)
PPP1R3C:glycogen-GYG2:GYS2-a tetramerComplexR-HSA-3777104 (Reactome)
PPP1R3C:phosphoglycogen-GYG1:GYS1-a tetramerComplexR-HSA-3777093 (Reactome)
PPP1R3C:phosphoglycogen-GYG2:GYS2-a tetramerComplexR-HSA-3777094 (Reactome)
PPP1R3CProteinQ9UQK1 (Uniprot-TrEMBL)
PPiMetaboliteCHEBI:29888 (ChEBI)
PXLP-PYGB ProteinP11216 (Uniprot-TrEMBL)
PXLP-PYGL ProteinP06737 (Uniprot-TrEMBL)
PXLP-PYGM ProteinP11217 (Uniprot-TrEMBL)
PXLP-p-S14-PYGB ProteinP11216 (Uniprot-TrEMBL)
PXLP-p-S15-PYGL ProteinP06737 (Uniprot-TrEMBL)
PXLP-p-S15-PYGM ProteinP11217 (Uniprot-TrEMBL)
PiMetaboliteCHEBI:18367 (ChEBI)
RPS27A(1-76) ProteinP62979 (Uniprot-TrEMBL)
UBA52(1-76) ProteinP62987 (Uniprot-TrEMBL)
UBB(1-76) ProteinP0CG47 (Uniprot-TrEMBL)
UBB(153-228) ProteinP0CG47 (Uniprot-TrEMBL)
UBB(77-152) ProteinP0CG47 (Uniprot-TrEMBL)
UBC(1-76) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(153-228) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(229-304) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(305-380) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(381-456) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(457-532) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(533-608) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(609-684) ProteinP0CG48 (Uniprot-TrEMBL)
UBC(77-152) ProteinP0CG48 (Uniprot-TrEMBL)
UDP-GlcMetaboliteCHEBI:18066 (ChEBI)
UDPMetaboliteCHEBI:17659 (ChEBI)
UGP2 ProteinQ16851 (Uniprot-TrEMBL)
UMPMetaboliteCHEBI:16695 (ChEBI)
UTPMetaboliteCHEBI:15713 (ChEBI)
UbComplexR-HSA-113595 (Reactome)
active PYGM and PYGB dimersComplexR-HSA-453340 (Reactome)
glycogen-GYG1 ProteinP46976 (Uniprot-TrEMBL)
glycogen-GYG1:GYS1-a tetramerComplexR-HSA-3322059 (Reactome)
glycogen-GYG1:GYS1-b tetramerComplexR-HSA-3322021 (Reactome)
glycogen-GYG2 ProteinO15488 (Uniprot-TrEMBL)
glycogen-GYG2:GYS2-a tetramerComplexR-HSA-3322011 (Reactome)
glycogen-glycogenin-1 dimerComplexR-HSA-453239 (Reactome)
glycogen-glycogenin-2 dimerComplexR-HSA-453240 (Reactome)
limit

dextrin-glycogenin

dimer
ComplexR-HSA-453336 (Reactome)
limit dextrin-glycogenin-1 dimerComplexR-HSA-453345 (Reactome)
limit dextrin-glycogenin-2 dimerComplexR-HSA-453330 (Reactome)
limit dextrin-glycogenin-1 ProteinP46976 (Uniprot-TrEMBL)
limit dextrin-glycogenin-2 ProteinO15488 (Uniprot-TrEMBL)
oligo((1,4)-alpha-glucosyl) GYG1 ProteinP46976 (Uniprot-TrEMBL)
oligo((1,4)-alpha-glycosyl) GYG2 ProteinO15488 (Uniprot-TrEMBL)
oligoGlc-GYG1:GYS1-a tetramerComplexR-HSA-3322035 (Reactome)
oligoGlc-GYG1:GYS1-b tetramerComplexR-HSA-3322053 (Reactome)
oligoGlc-GYG2:GYS2-a tetramerComplexR-HSA-3321999 (Reactome)
oligoGlc-GYG2:GYS2-b tetramerComplexR-HSA-3322007 (Reactome)
p-S-GYS1 ProteinP13807 (Uniprot-TrEMBL)
p-S-GYS2 ProteinP54840 (Uniprot-TrEMBL)
phosphorylase kinase complex (PHKL)ComplexR-HSA-71534 (Reactome)
phosphorylase kinase complex (PHKM)ComplexR-HSA-71520 (Reactome)
poly((1,4)-alpha-glucosyl)GYG dimerComplexR-HSA-453224 (Reactome)
poly((1,4)-alpha-glucosyl)GYG dimerComplexR-HSA-5357556 (Reactome)
poly((1,4)-alpha-glucosyl)GYG1 ProteinP46976 (Uniprot-TrEMBL)
poly((1,4)-alpha-glucosyl)GYG1 dimerComplexR-HSA-453217 (Reactome)
poly((1,4)-alpha-glucosyl)GYG2 ProteinO15488 (Uniprot-TrEMBL)
poly((1,4)-alpha-glucosyl)GYG2 dimerComplexR-HSA-453216 (Reactome)
polyGlc-GYG1:GYS1-a tetramerComplexR-HSA-3322054 (Reactome)
polyGlc-GYG1:GYS1-b tetramerComplexR-HSA-3322063 (Reactome)
polyGlc-GYG2:GYS2-a tetramerComplexR-HSA-3322056 (Reactome)
polysaccharide-P-GYG1 ProteinP46976 (Uniprot-TrEMBL)
polysaccharide-P-GYG2 ProteinO15488 (Uniprot-TrEMBL)

Annotated Interactions

View all...
SourceTargetTypeDatabase referenceComment
((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl)GYG dimerArrowR-HSA-71552 (Reactome)
((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl)GYG dimerR-HSA-5357585 (Reactome)
((1,6)-alpha-glucosyl)poly((1,4)-alpha-glucosyl)GYG dimerR-HSA-71593 (Reactome)
8xUGP2mim-catalysisR-HSA-70286 (Reactome)
ADPArrowR-HSA-453337 (Reactome)
ADPArrowR-HSA-71541 (Reactome)
ADPArrowR-HSA-71588 (Reactome)
AGLmim-catalysisR-HSA-71552 (Reactome)
AGLmim-catalysisR-HSA-71593 (Reactome)
AMPArrowR-HSA-453338 (Reactome)
AMPArrowR-HSA-453346 (Reactome)
AMPR-HSA-453342 (Reactome)
AMPR-HSA-453356 (Reactome)
ATPR-HSA-453337 (Reactome)
ATPR-HSA-71541 (Reactome)
ATPR-HSA-71588 (Reactome)
ATPTBarR-HSA-453342 (Reactome)
Ca2+ArrowR-HSA-71541 (Reactome)
Ca2+ArrowR-HSA-71588 (Reactome)
EPM2A dimerR-HSA-3781001 (Reactome)
EPM2A dimerR-HSA-3781021 (Reactome)
EPM2A:PPP1R3C:glycogen-GYG1:GYS1-a tetramerArrowR-HSA-3781018 (Reactome)
EPM2A:PPP1R3C:glycogen-GYG1:GYS1-a tetramerR-HSA-3781009 (Reactome)
EPM2A:PPP1R3C:glycogen-GYG2:GYS2-a tetramerArrowR-HSA-3781011 (Reactome)
EPM2A:PPP1R3C:glycogen-GYG2:GYS2-a tetramerR-HSA-3780995 (Reactome)
EPM2A:PPP1R3C:phosphoglycogen-GYG1:GYS1-a tetramerArrowR-HSA-3781001 (Reactome)
EPM2A:PPP1R3C:phosphoglycogen-GYG1:GYS1-a tetramerR-HSA-3781018 (Reactome)
EPM2A:PPP1R3C:phosphoglycogen-GYG1:GYS1-a tetramermim-catalysisR-HSA-3781018 (Reactome)
EPM2A:PPP1R3C:phosphoglycogen-GYG2:GYS2-a tetramerArrowR-HSA-3781021 (Reactome)
EPM2A:PPP1R3C:phosphoglycogen-GYG2:GYS2-a tetramerR-HSA-3781011 (Reactome)
EPM2A:PPP1R3C:phosphoglycogen-GYG2:GYS2-a tetramermim-catalysisR-HSA-3781011 (Reactome)
G1PArrowR-HSA-453339 (Reactome)
G1PArrowR-HSA-453358 (Reactome)
G1PArrowR-HSA-70272 (Reactome)
G1PArrowR-HSA-71515 (Reactome)
G1PArrowR-HSA-71590 (Reactome)
G1PR-HSA-70286 (Reactome)
G1PR-HSA-70427 (Reactome)
G6PArrowR-HSA-3322041 (Reactome)
G6PArrowR-HSA-70427 (Reactome)
G6PR-HSA-70272 (Reactome)
G6PTBarR-HSA-453342 (Reactome)
GAA (70, 76 kDa)mim-catalysisR-HSA-5357585 (Reactome)
GAA (70, 76 kDa)mim-catalysisR-HSA-5357589 (Reactome)
GBE1mim-catalysisR-HSA-3322005 (Reactome)
GBE1mim-catalysisR-HSA-3322016 (Reactome)
GBE1mim-catalysisR-HSA-3322057 (Reactome)
GYG1 dimerArrowR-HSA-453358 (Reactome)
GYG1:GYS1-a tetramerR-HSA-3322025 (Reactome)
GYG1:GYS1-a tetramermim-catalysisR-HSA-3322025 (Reactome)
GYG1:GYS1-b tetramerR-HSA-3322003 (Reactome)
GYG1:GYS1-b tetramermim-catalysisR-HSA-3322003 (Reactome)
GYG2 dimerArrowR-HSA-453339 (Reactome)
GYG2:GYS2-a tetramerR-HSA-3322014 (Reactome)
GYG2:GYS2-a tetramermim-catalysisR-HSA-3322014 (Reactome)
GYG2:GYS2-b tetramerR-HSA-3322019 (Reactome)
GYG2:GYS2-b tetramermim-catalysisR-HSA-3322019 (Reactome)
GlcArrowR-HSA-5357585 (Reactome)
GlcArrowR-HSA-5357589 (Reactome)
GlcArrowR-HSA-71593 (Reactome)
H2OR-HSA-3781011 (Reactome)
H2OR-HSA-3781018 (Reactome)
H2OR-HSA-5357585 (Reactome)
H2OR-HSA-5357589 (Reactome)
K48polyUb-EPM2AArrowR-HSA-3780995 (Reactome)
K48polyUb-EPM2AArrowR-HSA-3781009 (Reactome)
K48polyUb-PPP1R3CArrowR-HSA-3780995 (Reactome)
K48polyUb-PPP1R3CArrowR-HSA-3781009 (Reactome)
NHLRC1mim-catalysisR-HSA-3780995 (Reactome)
NHLRC1mim-catalysisR-HSA-3781009 (Reactome)
PGM:Mg2+mim-catalysisR-HSA-70272 (Reactome)
PGM:Mg2+mim-catalysisR-HSA-70427 (Reactome)
PGYB b dimer:AMPArrowR-HSA-453356 (Reactome)
PGYB b dimer:AMPR-HSA-453346 (Reactome)
PGYB dimer a formArrowR-HSA-453337 (Reactome)
PGYB dimer b formArrowR-HSA-453346 (Reactome)
PGYB dimer b formR-HSA-453337 (Reactome)
PGYB dimer b formR-HSA-453356 (Reactome)
PGYL dimer a formArrowR-HSA-71588 (Reactome)
PGYL dimer a formmim-catalysisR-HSA-453339 (Reactome)
PGYL dimer a formmim-catalysisR-HSA-71590 (Reactome)
PGYL dimer b formR-HSA-71588 (Reactome)
PGYM b dimer:AMPArrowR-HSA-453342 (Reactome)
PGYM b dimer:AMPR-HSA-453338 (Reactome)
PGYM dimer a formArrowR-HSA-71541 (Reactome)
PGYM dimer, b formArrowR-HSA-453338 (Reactome)
PGYM dimer, b formR-HSA-453342 (Reactome)
PGYM dimer, b formR-HSA-71541 (Reactome)
PPP1R3C:glycogen-GYG1:GYS1-a tetramerArrowR-HSA-3781023 (Reactome)
PPP1R3C:glycogen-GYG1:GYS1-a tetramerR-HSA-3781024 (Reactome)
PPP1R3C:glycogen-GYG1:GYS1-a tetramermim-catalysisR-HSA-3781024 (Reactome)
PPP1R3C:glycogen-GYG2:GYS2-a tetramerArrowR-HSA-3780997 (Reactome)
PPP1R3C:glycogen-GYG2:GYS2-a tetramerR-HSA-3780994 (Reactome)
PPP1R3C:glycogen-GYG2:GYS2-a tetramermim-catalysisR-HSA-3780994 (Reactome)
PPP1R3C:phosphoglycogen-GYG1:GYS1-a tetramerArrowR-HSA-3781024 (Reactome)
PPP1R3C:phosphoglycogen-GYG1:GYS1-a tetramerR-HSA-3781001 (Reactome)
PPP1R3C:phosphoglycogen-GYG2:GYS2-a tetramerArrowR-HSA-3780994 (Reactome)
PPP1R3C:phosphoglycogen-GYG2:GYS2-a tetramerR-HSA-3781021 (Reactome)
PPP1R3CR-HSA-3780997 (Reactome)
PPP1R3CR-HSA-3781023 (Reactome)
PPiArrowR-HSA-70286 (Reactome)
PiArrowR-HSA-3781011 (Reactome)
PiArrowR-HSA-3781018 (Reactome)
PiR-HSA-453339 (Reactome)
PiR-HSA-453358 (Reactome)
PiR-HSA-71515 (Reactome)
PiR-HSA-71590 (Reactome)
R-HSA-3322001 (Reactome) Unphosphorylated glycogen synthase 1 (GYS1-a) complexed with oligo-D-glucose-GYG1 catalyzes the polyglucosylation of the latter. (Here the addition of four glucose residues is annotated.) (Cameron et al. 2009; Roach et al. 2012).
R-HSA-3322003 (Reactome) Glycogenin 1 (GYG1) catalyzes its autoglycosylation reaction with UDP-glucose to form oligo (1,4)-alpha-D-glucosyl GYG1 (Moslemi et al. 2010). The oligosaccharide is annotated here as containing four glucose residues. Glycogenin occurs as a homodimer complexed with two molecules of glycogen synthase 1 (GYS1), here in a phosphorylated (b) form (Roach et al. 2012).
R-HSA-3322005 (Reactome) Cytosolic glycogen branching enzyme (GBE1) associated with glycogen granules transfers terminal alpha(1,4) glucose blocks to form alpha(1,6) branches on growing glycogen molecules formed on glycogenin 1 (GYG1) complexed with unphosphorylated glycogen synthase 1 (GYS1-a) (Bao et al. 1996; Roach et al. 2012).
R-HSA-3322009 (Reactome) Unphosphorylated glycogen synthase 2 (GYS2-a) complexed with oligo-D-glucose-GYG2 catalyzes the polyglucosylation of the latter. (Here the addition of four glucose residues is annotated.) (Orho et al. 1998; Roach et al. 2012).
R-HSA-3322014 (Reactome) Glycogenin 2 (GYG2) catalyzes its autoglycosylation reaction with UDP-glucose to form oligo (1,4)-alpha-D-glucosyl GYG2 (Mu et al. 1997). The oligosaccharide is annotated here as containing four glucose residues. Glycogenin occurs as a homodimer complexed with two molecules of glycogen synthase 1 (GYS2), here in a unphosphorylated (a) form (Roach et al. 2012).
R-HSA-3322016 (Reactome) Cytosolic glycogen branching enzyme (GBE1) associated with glycogen granules transfers terminal alpha(1,4) glucose blocks to form alpha(1,6) branches on growing glycogen molecules formed on glycogenin 2 (GYG2) complexed with unphosphorylated glycogen synthase 2 (GYS2-a) (Bao et al. 1996; Roach et al. 2012).
R-HSA-3322019 (Reactome) Glycogenin 2 (GYG2) catalyzes its autoglycosylation reaction with UDP-glucose to form oligo (1,4)-alpha-D-glucosyl GYG2 (Mu et al. 1997). The oligosaccharide is annotated here as containing four glucose residues. Glycogenin occurs as a homodimer complexed with two molecules of glycogen synthase 1 (GYS2), here in a phosphorylated (b) form (Roach et al. 2012).
R-HSA-3322025 (Reactome) Glycogenin 1 (GYG1) catalyzes its autoglycosylation reaction with UDP-glucose to form oligo (1,4)-alpha-D-glucosyl GYG1 (Moslemi et al. 2010). The oligosaccharide is annotated here as containing four glucose residues. Glycogenin occurs as a homodimer complexed with two molecules of glycogen synthase 1 (GYS1), here in an unphosphorylated (a) form (Roach et al. 2012).
R-HSA-3322041 (Reactome) Phosphorylated glycogen synthase 1 (GYS1-b) complexed with oligo-D-glucose-GYG1 catalyzes the polyglucosylation of the latter. (Here the addition of four glucose residues is annotated.) This reaction is allosterically activated by glucose-6-phosphate (G6P) (Cameron et al. 2009; Roach et al. 2012).
R-HSA-3322057 (Reactome) Cytosolic glycogen branching enzyme (GBE1) associated with glycogen granules transfers terminal alpha(1,4) glucose blocks to form alpha(1,6) branches on growing glycogen molecules formed on glycogenin 1 (GYG1) complexed with phosphorylated glycogen synthase 1 (GYS1-b) (Bao et al. 1996; Roach et al. 2012).
R-HSA-3780994 (Reactome) Glycogen synthase 2 (GYS2) catalyzes the incorporation of phosphoglucose into the glycogen-GYG1 molecules with which it is associated in a cytosolic glycogen granule. This reaction occurs at a low rate, yielding approximately one molecule of glucose phosphorylated at its C2, C3, or C6 positions incorporated into a growing glycogen polymer per ten thousand glucose molecules incorporated (DePaoli-Roach et al. 2015; Irimia et al. 2015; Nitschke et al. 2013; Tagliabracci et al. 2011). The function of these small amounts of phosphoglucose in normal glycogen remains to be established. This reaction has been characterized in muscle cells, where it is catalyzed by the homologous GYS1 enzyme. The occurrence of the reaction in liver, catalyzed by GYS2, can be inferred from the fact that in the absence of the enzyme EMP2A (laforin) that removes these phosphate groups, abnormally phosphorylated glycogen accumulates in both tissues (Worby et al. 2008).
R-HSA-3780995 (Reactome) NHLRC1 (malin) associates with the glycogen particle where it functions as a ubiquitin E3 ligase to mediate the polyubiquitination of EPM2A (laforin) and PPP1R3C (protein phosphatase 1 regulatory subunit 3C, PTG). The two polyubiquitinated proteins are targeted for proteasome-mediated degradation, leaving a glycogen-GYG2 particle associated with glycogen synthase 2 GYS2 (Gentry et al. 2005, Worby et al. 2008). In NHLRC1 knockout mice, PPP1R3C levels are unchanged, rather than increased, suggesting that NHLRC1 does not target PPP1R3C for degradation. However, EPM2A protein levels are increased in this knockout consistent with NHLRC1's proposed role. (DePaoli-Roach et al. 2010). This process is inferred from studies of muscle glycogen and from the fact that defects in either EPM2A or NHLRC1 lead to formation of similar aberrant glycogen particles in both tissues.
R-HSA-3780997 (Reactome) Protein phosphatase 1 regulatory subunit 3C (PPP1R3C, PTG) binds to glycogen particles containing GYG2 (glycogenin 2) and GYS2 (glycogen synthase 2). PPP1R3C appears to function as a scaffolding protein to mediate association of other proteins with glycogen granules and to promote the synthesis of glycogen (Worby et al. 2008). This reaction, involving GYG and GYS isoforms largely expressed in the liver has not been studied in detail but is inferred from the better-characterized one involving GYG1- and GYS1-containing glycogen particles ("muscle" isoforms, widely expressed in the body outside the liver).
R-HSA-3781001 (Reactome) EPM2A (laforin) dimer binds to the PPP1R3C:phosphoglycogen-GYG1 (glycogenin 1) complex, probably through interactions with the PPP1R3C (PTG) and glycogen moieties of the complex (Worby et al. 2008).
R-HSA-3781009 (Reactome) NHLRC1 (malin) associates with the glycogen particle where it functions as a ubiquitin E3 ligase to mediate the polyubiquitination of EPM2A (laforin) and PPP1R3C (PTG). The two polyubiquitinated proteins are targeted for proteasome-mediated degradation, leaving a glycogen-GYG1 particle associated with GYS1 (Gentry et al. 2005, Worby et al. 2008). In NHLRC1 knockout mice, PPP1R3C levels are unchanged, rather than increased, suggesting that NHLRC1 does not target PPP1R3C for degradation. However, EPM2A protein levels are increased in this knockout consistent with NHLRC1's proposed role (DePaoli-Roach et al. 2010).
R-HSA-3781011 (Reactome) EPM2A (laforin), associated with PPP1R3C (protein phosphatase 1 regulatory subunit 3C, PTG) and phosphoglycogen-GYG2 in a cytosolic glycogen particle, catalyzes the dephosphorylation of phosphoglycogen (Tagliabracci et al. 2007). This reaction is inferred from the activity of EPM2A on phosphoglycogen-GYG1, and from the fact that in the absence of normal EPM2A activity, abnormally phosphorylated forms of both glycogen-GYG1 and glycogen-GYG2 accumulate in cells. The catalytically active form of EPM2A has been shown to be a homodimer (Raththagala et al. 2015; Sankhala et al. 2015).
R-HSA-3781018 (Reactome) EPM2A (laforin), associated with PPP1R3C (protein phosphatase 1 regulatory subunit 3C, PTG) and phosphoglycogen-GYG1 in a cytosolic glycogen particle, catalyzes the dephosphorylation of phosphoglycogen (Tagliabracci et al. 2007). The catalytically active form of EPM2A has been shown to be a homodimer (Raththagala et al. 2015; Sankhala et al. 2015).
R-HSA-3781021 (Reactome) EPM2A (laforin) dimer binds to the PPP1R3C:phosphoglycogen-GYG2 (glycogenin 2) complex, probably through interactions with the PPP1R3C (PTG) and glycogen moieties of the complex (Worby et al. 2008). This reaction is inferred from the properties of the better studied muscle glycogen particles containing GYG1 (glycogenin 1), and from the fact that in the absence of EMP2A (laforin) function, liver glycogen particles become abnormal in the same way as do muscle particles.
R-HSA-3781023 (Reactome) Protein phosphatase 1 regulatory subunit 3C (PPP1R3C, PTG) binds to glycogen particles containing GYG1 (glycogenin 1) and GYS1 (glycogen synthase 1). PPP1R3C appears to function as a scaffolding protein to mediate association of other proteins with glycogen granules and to promote the synthesis of glycogen (Worby et al. 2008).
R-HSA-3781024 (Reactome) Glycogen synthase 1 (GYS1) catalyzes the incorporation of phosphoglucose into the glycogen-GYG1 molecules with which it is associated in a cytosolic glycogen granule. This reaction occurs at a low rate, yielding approximately one molecule of glucose phosphorylated at its C2, C3, or C6 positions incorporated into a growing glycogen polymer per ten thousand glucose molecules incorporated (DePaoli-Roach et al. 2015; Irimia et al. 2015; Nitschke et al. 2013; Tagliabracci et al. 2011). The function of these small amounts of phosphoglucose in normal glycogen remains to be established.
R-HSA-453337 (Reactome) The phosphorylation of glycogen phosphorylase PYGB by the widely expressed form of the phosphorylase kinase complex is inferred from its activity on PGYM (Newgard et al. 1989).
R-HSA-453338 (Reactome) Cytosolic, non-phosphorylated PGYM dimers (b form) complexed with AMP can reversibly dissociate (Rath et al. 2000).
R-HSA-453339 (Reactome) The phosphorylated PYGL dimer (a form) of glycogen phosphorylase catalyzes the reaction of orthophosphate and poly((1,4)-alpha-glucosyl) glycogenin-2 to form D-glucose 1-phosphate and glycogenin-2. This reaction occurs on the surfaces of cytosolic glycogen granules. Non-phosphorylated PYGL dimers (b form) are catalytically inactive even in the presence of AMP. In the body, this reaction takes place in the liver where its dependence on hormonally stimulated PYGL phosphorylation (and lack of sensitivity to AMP) allow glucose mobilization in response to a demand for glucose from the rest of the body (Newgard et al. 1989; Rath et al. 2000).
R-HSA-453342 (Reactome) Cytosolic, non-phosphorylated PGYM dimers (b form) can reversibly bind AMP. This reaction is negatively regulated by ATP and glucose 6-phosphate and is the means by which high levels of these molecules repress PGYM activity (Rath et al. 2000).
R-HSA-453346 (Reactome) Cytosolic, non-phosphorylated PGYB dimers (b form) complexed with AMP can reversibly dissociate. This reaction is inferred from the AMP-binding properties of the closely homologous PGYM complex (Rath et al. 2000).
R-HSA-453356 (Reactome) Cytosolic, non-phosphorylated PGYB dimers (b form) can reversibly bind AMP. This reaction is inferred from the AMP-binding properties of human PGYL and closely homologous PGYM proteins from other species (Newgard et al. 1989; Rath et al. 2000).
R-HSA-453358 (Reactome) The PYGM and PYGB forms of glycogen phosphorylase catalyze the reaction of orthophosphate and poly((1,4) alpha glucosyl) glycogenin-1 to form D-glucose 1-phosphate and glycogenin-1. This reaction occurs on the surfaces of cytosolic glycogen granules. The phosphorylated forms of PYGM and PYGB dimers (a form) are catalytically active; the non-phosphorylated dimers (b form) become active when complexed with AMP. In the body, this reaction takes place in tissues other than the liver where its sensitivity to AMP allows glucose mobilization in response to acute energy needs of the individual cell, and hormonally mediated phosphorylation can stimulate increased glucose production, still for use by the individual producing cell, in response to stress signals. These reactions have not been characterized in detail but are inferred to occur from the very close similarity among PGYM, PGYB, and PGYL (Newgard et al. 1989; Rath et al. 2000).
R-HSA-5357585 (Reactome) Lysosomal alpha-glucosidase (GAA) catalyzes the hydrolysis of alpha(1,6) linkages in partly hydrolyzed glycogen, removing single (1,6)-linked glucose residues attached to (1,4) chains. The most active forms of GAA are 70 and 76 kDa polypeptides generated by removal of both aminoterminal and carboxyterminal fragments (Brown et al. 1970; Hoefsloot et al. 1988; Wisselaar et al. 1993).
R-HSA-5357589 (Reactome) Lysosomal alpha-glucosidase (GAA) catalyzes the hydrolysis of alpha(1,4) linkages in glycogen, yielding free glucose and glycogen polymers shorter by one glucose residue. The most active forms of GAA are 70 and 76 kDa polypeptides generated by removal of both aminoterminal and carboxyterminal fragments (Brown et al. 1970; Hoefsloot et al. 1988; Wisselaar et al. 1993).
R-HSA-70272 (Reactome) Cytosolic phosphoglucomutase (PGM) catalyses the reversible conversion of glucose 6-phosphate (G6P) to glucose 1-phosphate (G1P) (Drago et al. 1991). Two PGM isoenzymes, both monomers, have been identified which both require Mg2+ as cofactor. PGM1 is the major form found in most tissues except erythrocytes, where PGM2 is abundant (March et al. 1993; Parrington et al. 1968; Putt et al. 1993). PGM2 also has substantial phosphopentomutase activity (Maliekal et al. 2007) and its primary physiological in normal tissues in vivo is not clear. Cytosolic glucose 1,6-bisphosphate synthase (PGM2L1) also possesses phosphoglucomutase activity (Maliekal et al. 2007, Veiga-da-Cunha et al. 2008).
R-HSA-70286 (Reactome) Cytosolic UDP-glucose pyrophosphorylase 2 (UGP2) catalyzes the reaction of UTP and glucose 1-phosphate to form UDP glucose and pyrophosphate (Knop and Hansen 1970; Duggleby et al. 1996). UGP2 is inferred to occur in the cell as a homooctamer from studies of its bovine homologue (Levine et al. 1969).
R-HSA-70427 (Reactome) Cytosolic phosphoglucomutase (PGM) catalyzes the reversible conversion of glucose 1-phosphate to glucose 6-phosphate. Two PGM isoenzymes, both monomers, have been identified. PGM1 is the major form found in most tissues except erythrocytes, where PGM2 is abundant (March et al. 1993; Parrington et al. 1968; Putt et al. 1993). PGM2 also has substantial phosphopentomutase activity and its primary physiological in normal tissues in vivo is not clear. Cytosolic glucose 1,6-bisphosphate synthase (PGM2L1) also possesses phosphoglucomutase activity (Maliekal et al. 2007, Veiga-da-Cunha et al. 2008).
R-HSA-71515 (Reactome) The PYGM and PYGB forms of glycogen phosphorylase catalyze the reaction of orthophosphate and glycogen-glycogenin 1 to form D-glucose 1-phosphate and limit dextrin-glycogenin 1. This reaction occurs on the surfaces of cytosolic glycogen granules. The phosphorylated forms of PYGM and PYGB dimers (a form) are catalytically active; the non-phosphorylated dimers (b form) become active when complexed with AMP. In the body, this reaction takes place in tissues other than the liver where its sensitivity to AMP allows glucose mobilization in response to acute energy needs of the individual cell, and hormonally mediated phosphorylation can stimulate increased glucose production, still for use by the individual producing cell, in response to stress signals. These reactions have not been characterized in detail but are inferred to occur from the very close similarity among PGYM, PGYB, and PGYL (Newgard et al. 1989; Rath et al. 2000).
R-HSA-71541 (Reactome) The cytosolic phosphorylase kinase complex catalyzes the phosphorylation of the subunits of the glycogen phosphorylase (PYGM) dimer. Two forms of phosphorylase kinase complex have been described (Brushia and Walsh 1999). The one annotated here, consisting of four copies each of PHKA1 (alpha regulatory) (Burwinkel et al 2003), PHKB (beta regulatory) (Burwinkel et al. 2003), PHKG1 (gamma catalytic) (Burwinkel et al. 2003) and CALM (calmodulin) subunits is abundant in muscle and its action on the form of phosphorylase (PYGM) abundant in muscle is described.

While initial studies of PGYM from rabbit muscle suggested that it is a homotetramer (Keller and Cori 1953), more recent work indicates that under physiological conditions the enzyme occurs as a homodimer (Huang and Graves 1970) and a dimeric structure for the human enzyme is inferred here.

R-HSA-71552 (Reactome) Cytosolic debranching enzyme associated with glycogen granules transfers 3-glucose blocks from branches to the main linear polyglucose chain of limit dextrin formed on glycogenin 1 or glycogenin 2 (Chen et al. 1988; Shen et al. 1996).
R-HSA-71588 (Reactome) The cytosolic phosphorylase kinase complex catalyzes the phosphorylation of glycogen phosphorylase (PYGL). Two forms of phosphorylase kinase complex have been described (Brushia and Walsh 1999). The one annotated here, consisting of four copies each of PHKA2 (alpha regulatory) (van den Berg et al. 1995), PHKB (beta regulatory) (Burwinkel et al. 2003a), PHKG2 (gamma catalytic) (Burwinkel et al. 2003b; Maichele et al. 2006) and CALM (calmodulin) subunits is abundant in liver and its action on the form of phosphorylase (PYGL) abundant in liver is described.

While initial studies of glycogen phosphorylase PGYM from rabbit muscle suggested that it is a homotetramer (Keller and Cori 1953), more recent work indicates that under physiological conditions the enzyme occurs as a homodimer (Huang and Graves 1970) and a dimeric structure for human PYGL enzyme is inferred here.

R-HSA-71590 (Reactome) The phosphorylated PYGL dimer (a form) of glycogen phosphorylase catalyzes the reaction of orthophosphate and glycogen-glycogenin 1 to form D-glucose 1-phosphate and limit dextrin-glycogenin 1. This reaction occurs on the surfaces of cytosolic glycogen granules. Non-phosphorylated PYGL dimers (b form) are catalytically inactive even in the presence of AMP. In the body, this reaction takes place in the liver where its dependence on hormonally stimulated PYGL phosphorylation (and lack of sensitivity to AMP) allow glucose mobilization in response to a demand for glucose from the rest of the body (Newgard et al. 1989; Rath et al. 2000).
R-HSA-71593 (Reactome) At the beginning of this reaction, 1 molecule of '{(1,6)-alpha-glucosyl}poly{(1,4)-alpha-glucosyl}glycogenin-2' is present. At the end of this reaction, 1 molecule of 'alpha-D-glucose', and 1 molecule of 'poly{(1,4)-alpha-glucosyl}glycogenin-2' are present.

This reaction takes place in the 'cytoplasm' and is mediated by the 'amylo-alpha-1,6-glucosidase activity' of 'glycogen debranching enzyme'.

UDP-GlcArrowR-HSA-70286 (Reactome)
UDP-GlcR-HSA-3322001 (Reactome)
UDP-GlcR-HSA-3322003 (Reactome)
UDP-GlcR-HSA-3322009 (Reactome)
UDP-GlcR-HSA-3322014 (Reactome)
UDP-GlcR-HSA-3322019 (Reactome)
UDP-GlcR-HSA-3322025 (Reactome)
UDP-GlcR-HSA-3322041 (Reactome)
UDP-GlcR-HSA-3780994 (Reactome)
UDP-GlcR-HSA-3781024 (Reactome)
UDPArrowR-HSA-3322001 (Reactome)
UDPArrowR-HSA-3322003 (Reactome)
UDPArrowR-HSA-3322009 (Reactome)
UDPArrowR-HSA-3322014 (Reactome)
UDPArrowR-HSA-3322019 (Reactome)
UDPArrowR-HSA-3322025 (Reactome)
UDPArrowR-HSA-3322041 (Reactome)
UMPArrowR-HSA-3780994 (Reactome)
UMPArrowR-HSA-3781024 (Reactome)
UTPR-HSA-70286 (Reactome)
UbR-HSA-3780995 (Reactome)
UbR-HSA-3781009 (Reactome)
active PYGM and PYGB dimersmim-catalysisR-HSA-453358 (Reactome)
active PYGM and PYGB dimersmim-catalysisR-HSA-71515 (Reactome)
glycogen-GYG1:GYS1-a tetramerArrowR-HSA-3322005 (Reactome)
glycogen-GYG1:GYS1-a tetramerArrowR-HSA-3781009 (Reactome)
glycogen-GYG1:GYS1-a tetramerR-HSA-3781023 (Reactome)
glycogen-GYG1:GYS1-b tetramerArrowR-HSA-3322057 (Reactome)
glycogen-GYG2:GYS2-a tetramerArrowR-HSA-3322016 (Reactome)
glycogen-GYG2:GYS2-a tetramerArrowR-HSA-3780995 (Reactome)
glycogen-GYG2:GYS2-a tetramerR-HSA-3780997 (Reactome)
glycogen-glycogenin-1 dimerR-HSA-71515 (Reactome)
glycogen-glycogenin-2 dimerR-HSA-71590 (Reactome)
limit

dextrin-glycogenin

dimer
R-HSA-71552 (Reactome)
limit dextrin-glycogenin-1 dimerArrowR-HSA-71515 (Reactome)
limit dextrin-glycogenin-2 dimerArrowR-HSA-71590 (Reactome)
oligoGlc-GYG1:GYS1-a tetramerArrowR-HSA-3322025 (Reactome)
oligoGlc-GYG1:GYS1-a tetramerR-HSA-3322001 (Reactome)
oligoGlc-GYG1:GYS1-a tetramermim-catalysisR-HSA-3322001 (Reactome)
oligoGlc-GYG1:GYS1-b tetramerArrowR-HSA-3322003 (Reactome)
oligoGlc-GYG1:GYS1-b tetramerR-HSA-3322041 (Reactome)
oligoGlc-GYG1:GYS1-b tetramermim-catalysisR-HSA-3322041 (Reactome)
oligoGlc-GYG2:GYS2-a tetramerArrowR-HSA-3322014 (Reactome)
oligoGlc-GYG2:GYS2-a tetramerR-HSA-3322009 (Reactome)
oligoGlc-GYG2:GYS2-a tetramermim-catalysisR-HSA-3322009 (Reactome)
oligoGlc-GYG2:GYS2-b tetramerArrowR-HSA-3322019 (Reactome)
phosphorylase kinase complex (PHKL)mim-catalysisR-HSA-71588 (Reactome)
phosphorylase kinase complex (PHKM)mim-catalysisR-HSA-453337 (Reactome)
phosphorylase kinase complex (PHKM)mim-catalysisR-HSA-71541 (Reactome)
poly((1,4)-alpha-glucosyl)GYG dimerArrowR-HSA-5357585 (Reactome)
poly((1,4)-alpha-glucosyl)GYG dimerArrowR-HSA-5357589 (Reactome)
poly((1,4)-alpha-glucosyl)GYG dimerArrowR-HSA-71593 (Reactome)
poly((1,4)-alpha-glucosyl)GYG dimerR-HSA-5357589 (Reactome)
poly((1,4)-alpha-glucosyl)GYG1 dimerR-HSA-453358 (Reactome)
poly((1,4)-alpha-glucosyl)GYG2 dimerR-HSA-453339 (Reactome)
polyGlc-GYG1:GYS1-a tetramerArrowR-HSA-3322001 (Reactome)
polyGlc-GYG1:GYS1-a tetramerR-HSA-3322005 (Reactome)
polyGlc-GYG1:GYS1-b tetramerArrowR-HSA-3322041 (Reactome)
polyGlc-GYG1:GYS1-b tetramerR-HSA-3322057 (Reactome)
polyGlc-GYG2:GYS2-a tetramerArrowR-HSA-3322009 (Reactome)
polyGlc-GYG2:GYS2-a tetramerR-HSA-3322016 (Reactome)
Personal tools